Drug utilization study on pediatric pneumonia patients in a tertiary care teaching hospital
International Journal of Health Care and Biological Sciences · 2021
DOI: 10.46795/ijhcbs.v2i4.249 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Health Care and Biological Sciences, 2021. Verfasst von Ashmi SK und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Pneumonia remains the prime infectious disease that increases the mortality rate among children under five claimed the lives of nearly 1.5 million children in 2015. Mortality due to childhood pneumonia is linked to the prevalence and relapse increases and usage of antibiotics is more. In such circumstances, the main.
Aim
The Aim of the study was to assess the utilization of drugs and to spot the factors that contribute to the pediatric pneumonia patients at tertiary care teaching hospitals. Material and methods: A prospective, observational study was conducted from May 2021 to October 2021Overall 310 prescriptions were collected, 204 patients were included in the study based on inclusion criteria and data was collected from a proforma and by using WHO prescribing indicators study is analyzed.
Results
Age group with pneumonia of
Zitieren
APA
SK, A., & Y, H. (2021). Drug utilization study on pediatric pneumonia patients in a tertiary care teaching hospital. International Journal of Health Care and Biological Sciences. https://doi.org/10.46795/ijhcbs.v2i4.249
Vancouver
SK A, Y H. Drug utilization study on pediatric pneumonia patients in a tertiary care teaching hospital. International Journal of Health Care and Biological Sciences. 2021. doi:10.46795/ijhcbs.v2i4.249
BibTeX
@article{SK2021,
author = {SK, Ashmi and Y, Hafeeza},
title = {Drug utilization study on pediatric pneumonia patients in a tertiary care teaching hospital},
journal = {International Journal of Health Care and Biological Sciences},
year = {2021},
doi = {10.46795/ijhcbs.v2i4.249}
}
EUVIMED